Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis.

Ruttens, D; Philippet, P; Bucciol, G; Meyts, I

Ruttens, D; Philippet, P; Bucciol, G; Meyts, I.

Affiliation

Ruttens D; Department of Pediatrics, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
Philippet P; Division of Pediatric Immuno-hematology and Oncology, CHC MontLégia, Liège, Belgium.
Bucciol G; Inborn Errors of Immunity, Department of Immunology, Microbiology and Transplantation, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
Meyts I; Childhood Immunology, Department of Pediatrics, University Hospitals Leuven, ERN-RITA Core Member, Herestraat 49, 3000, Leuven, Belgium.

J Clin Immunol ; 43(8): 1758-1765, 2023 11.

Article in En | MEDLINE | ID: mdl-37578614

Subject(s)

Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Mucormycosis; Humans; Mucormycosis/diagnosis; Mucormycosis/etiology; Granulomatous Disease, Chronic/complications; Granulomatous Disease, Chronic/diagnosis; Granulomatous Disease, Chronic/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Granulomatous Disease, Chronic / Mucormycosis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Immunol Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google